AsiaMedic Limited (SGX:505)

AsiaMedic Statistics

Total Valuation

AsiaMedic has a market cap or net worth of SGD 19.20 million. The enterprise value is 32.64 million.

Market Cap	19.20M
Enterprise Value	32.64M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AsiaMedic has 1.13 billion shares outstanding. The number of shares has decreased by -0.67% in one year.

Current Share Class	1.13B
Shares Outstanding	1.13B
Shares Change (YoY)	-0.67%
Shares Change (QoQ)	-2.17%
Owned by Insiders (%)	13.03%
Owned by Institutions (%)	n/a
Float	516.56M

Valuation Ratios

The trailing PE ratio is 18.09.

PE Ratio	18.09
Forward PE	n/a
PS Ratio	0.59
PB Ratio	1.20
P/TBV Ratio	1.37
P/FCF Ratio	20.80
P/OCF Ratio	5.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.22, with an EV/FCF ratio of 35.36.

EV / Earnings	30.35
EV / Sales	1.00
EV / EBITDA	8.22
EV / EBIT	48.50
EV / FCF	35.36

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 1.25.

Current Ratio	1.79
Quick Ratio	1.65
Debt / Equity	1.25
Debt / EBITDA	5.52
Debt / FCF	21.64
Interest Coverage	0.40

Financial Efficiency

Return on equity (ROE) is 0.91% and return on invested capital (ROIC) is 0.69%.

Return on Equity (ROE)	0.91%
Return on Assets (ROA)	0.56%
Return on Invested Capital (ROIC)	0.69%
Return on Capital Employed (ROCE)	0.92%
Revenue Per Employee	833,160
Profits Per Employee	27,576
Employee Count	39
Asset Turnover	0.90
Inventory Turnover	81.70

Taxes

Income Tax	-4,177
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.55% in the last 52 weeks. The beta is 0.06, so AsiaMedic's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	+54.55%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	67.30
Average Volume (20 Days)	1,922,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AsiaMedic had revenue of SGD 32.49 million and earned 1.08 million in profits. Earnings per share was 0.00.

Revenue	32.49M
Gross Profit	7.44M
Operating Income	322,445
Pretax Income	129,410
Net Income	1.08M
EBITDA	1.08M
EBIT	322,445
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 8.60 million in cash and 19.98 million in debt, giving a net cash position of -11.38 million or -0.01 per share.

Cash & Cash Equivalents	8.60M
Total Debt	19.98M
Net Cash	-11.38M
Net Cash Per Share	-0.01
Equity (Book Value)	16.04M
Book Value Per Share	0.01
Working Capital	6.72M

Cash Flow

In the last 12 months, operating cash flow was 3.46 million and capital expenditures -2.53 million, giving a free cash flow of 923,195.

Operating Cash Flow	3.46M
Capital Expenditures	-2.53M
Free Cash Flow	923,195
FCF Per Share	0.00

Margins

Gross margin is 22.91%, with operating and profit margins of 0.99% and 3.31%.

Gross Margin	22.91%
Operating Margin	0.99%
Pretax Margin	0.40%
Profit Margin	3.31%
EBITDA Margin	3.31%
EBIT Margin	0.99%
FCF Margin	2.84%

Dividends & Yields

AsiaMedic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.67%
Shareholder Yield	n/a
Earnings Yield	5.60%
FCF Yield	4.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AsiaMedic has an Altman Z-Score of 0.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.63
Piotroski F-Score	6